Internal Medicine, Endocrinology, Diabetes, & Metabolism · Winchester, MA
NPI
1578531505
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
955 Main St, Suite 301
Winchester, MA, 01890
Phone (781) 721-3581
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,055 services
Medicare patients, 2024
546
Average age 75
Drug cost, 2024
$2.2M
10,396 prescriptions
Company payments, 2025
$166
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nada Kerouz was code 99214 (office e&m - established), 417 times for 294 patients. In total Nada Kerouz billed 1,055 services in 20 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 417 | 294 | $108.16 | $45K |
| 99215 Office E&M - Established | Office | 412 | 321 | $148.58 | $61K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 42 | 42 | $144.62 | $6,074 |
| 99213 Office E&M - Established | Office | 34 | 31 | $78.58 | $2,672 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 20 | 19 | $14.18 | $284 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 16 | 16 | $183.35 | $2,934 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 12 | 12 | $43.99 | $528 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 11 | 11 | $50.85 | $559 |
By year: 2022 $114K for 989 services; 2023 $120K for 988 services; 2024 $123K for 1,055 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nada Kerouz prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,084 prescriptions and refills. In total Nada Kerouz wrote 10,396 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,084 | 3,066 | 286 | $9,303 |
| Mounjaro Tirzepatide | 445 | 556 | 69 | $584K |
| Atorvastatin Calcium Generic | 340 | 989 | 99 | $4,188 |
| Famotidine Generic | 290 | 838 | 102 | $3,877 |
| Levoxyl Levothyroxine Sodium | 284 | 826 | 85 | $12K |
| Synthroid Levothyroxine Sodium | 260 | 626 | 66 | $14K |
| Montelukast Sodium Generic | 248 | 723 | 86 | $4,253 |
| Jardiance Empagliflozin | 230 | 476 | 51 | $271K |
| Metformin Hcl Er Metformin Hcl | 214 | 624 | 74 | $3,670 |
| Omeprazole Generic | 205 | 614 | 62 | $2,193 |
| Metformin Hcl Generic | 198 | 581 | 58 | $1,765 |
| Ozempic Semaglutide | 193 | 306 | 42 | $290K |
| Gabapentin Generic | 181 | 377 | 52 | $2,629 |
| Simvastatin Generic | 180 | 532 | 55 | $1,484 |
| Olmesartan Medoxomil Generic | 177 | 498 | 53 | $9,807 |
Brand drugs: 2,553 claims; generic drugs: 7,755 claims; opioid claims: 106.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nada Kerouz $166 ($166 in general payments such as food, travel and fees) from 2 companies. The largest payer was Madrigal Pharmaceuticals with $137.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.